- Home
- CNNE vs FDMT Comparison
CNNE vs FDMT Comparison
Compare CNNE & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNNE | FDMT |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.0M | 695.3M |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CNNE | FDMT |
|---|---|---|
| Price | $14.80 | $11.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $20.25 | ★ $31.71 |
| AVG Volume (30 Days) | 446.6K | ★ 1.0M |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | ★ 4.47% | N/A |
| EPS Growth | N/A | ★ 18.79 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $499,700,000.00 | $85,209,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $70.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 3.37 | ★ 230194.60 |
| 52 Week Low | $10.46 | $4.27 |
| 52 Week High | $21.92 | $14.00 |
Technical Indicators
Market Signals| Indicator | CNNE | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 55.16 | 50.09 |
| Support Level | $13.97 | $8.43 |
| Resistance Level | $14.99 | $11.85 |
| Average True Range (ATR) | 0.42 | 0.83 |
| MACD | 0.01 | -0.26 |
| Stochastic Oscillator | 52.46 | 31.17 |
Price Performance
Historical ComparisonAbout CNNE Cannae Holdings Inc.
Cannae Holdings Inc is an investment holding company that acquires and actively manages equity interests in operating businesses across various industries. The Company focuses on long-term ownership and seeks to create value by supporting the growth and operations of its portfolio companies through management expertise and strategic oversight. The Company operates through four reportable segments: Restaurant Group, which includes the operations of O'Charleys and 99 Restaurants; Alight, which represents its ownership interest in a technology-enabled human capital and employee benefits solutions provider; Black Knight Football Club (BKFC), which holds interests in professional football clubs; and JANA, which represents its investment in an investment management firm.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).